AGTC to Present at Upcoming Cell & Gene Meeting on the Mesa
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal diseases (IRDs), today announced Sue Washer, President and Chief Executive Officer of AGTC, will present at the 2021 Cell & Gene Meeting on the Mesa being held October 12-14, 2021.
Ms. Washer will provide a corporate update including AGTC’s plans to move late-stage X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM) clinical programs forward. The presentation will take place on October 13, 2021 at 11:15 AM PT.
Spectrum Science Communications
T: (202) 955-6222 or (310) 710-0321
Chief Business Officer
Applied Genetic Technologies Corporation
T: (617) 413-2754
Smart Government â€“ Digital Signage and Citizen Kiosks
Welcome Reception - For Paid Conference Pass Holders, Exhibitors, Sponsors, Speakers, Press
Session Details TBA